| Metric | შპს ფარმაცევტული სახლი + | შპს SmartPharm | შპს იბერიფარმა + |
|---|---|---|---|
| Growth | |||
| Revenue | ₾54.7m₾40.3m | ₾32.2m₾23.8m | ₾7.2m₾7.1m |
| Revenue growth | 35.6% | 35.4% | 2.2% |
| Profitability | |||
| EBITDA | -₾3.2m-₾930k | ₾2.9m₾2.7m | -₾778k-₾152k |
| EBITDA margin | -5.9%-2.3% | 9.1%11.4% | -10.7%-2.1% |
| Net profit | -₾1.6m-₾3.3m | ₾2.6m | |
| -₾778k-₾152k |
| Net margin | -3.0%-8.2% | 8.0%10.2% | -10.7%-2.1% |
| Balance sheet | |||
| Total assets | ₾38.3m₾34.8m | ₾10.8m₾8.5m | ₾1.6m₾1.8m |
| Total equity | -₾2.9m-₾1.3m | ₾7.2m₾4.9m | -₾1.1m-₾344k |
| ROE | — | 35.6%49.1% | — |